Kidney tumors in children: specific diagnosis with MRI

Justine van der Beek researched how different types of kidney tumors can be distinguished using MRI scans.

World-class collaboration receives €37.5 million for regenerative medicine using smart materials

Study of new treatment for severe influenza pneumonia

Van elke vijf patiënten die met ernstige longontsteking door influenza op de intensive care (IC) worden opgenomen, overlijdt er gemiddeld één. Om dit relatief hoge risico op overlijden te verlagen, gaan Nederlandse onderzoekers onder leiding van UMC Utrecht geneesmiddelen die eerder succesvol waren bij de behandeling van patiënten met ernstige Covid-19 op de IC terecht kwamen, nu ook onderzoeken bij IC-patiënten met ernstige longontsteking door influenza. ZonMw heeft voor deze studie een subsidie van ruim € 2.1 miljoen beschikbaar gesteld.

Sabine Fuchs appointed professor

How do we improve care for patients with rare diseases for which there are currently no treatments? This question is central to the work of pediatrician Sabine Fuchs. She has been appointed professor of Metabolic diseases and innovative therapies at the UMC Utrecht as of April 15, 2024. ‘I want to make these types of diseases treatable by also focusing on the other organs.’

Grant for research teams UMC Utrecht from ZonMw Open Competition

Five research teams of the UMC Utrecht receive a grant for projects in the framework of the ZonMw Open Competition. With this funding, the research teams can develop innovative team science initiatives that contribute to innovation within fundamental (bio)medical science and long-term health care. Within all projects, the research teams collaborate with other knowledge institutions. A total of 29 projects were honored for an amount of 23 million euros.

UMC Utrecht and Philips speed up development of image-guided treatments

UMC Utrecht and Philips are bringing together healthcare professionals, researchers and technicians in a 'fieldlab'. Here, they will develop new innovative technology and software to benefit healthcare. The goal is to devise less burdensome and more efficient treatments for patients, while at the same time realizing a more sustainable healthcare system.

New study speeds up radiation therapy

A targeted radiation therapy that lasts only 15 minutes, instead of 45 minutes. Plus: an even more precise, real-time treatment of the tumor. These are the two goals of a new study by UMC Utrecht to further innovate the MR-Linac. NWO has granted 1.7 million euros to this research project.

Four new cancer research projects at UMC Utrecht receive Hanarth grants

How can artificial intelligence be used to improve treatment in cancer patients? Researchers from UMC Utrecht are working on this question. Four research projects at UMC Utrecht received funding for this from the Hanarth Fonds.

GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)

GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in the detection and treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Supported by the Innovative Health Initiative Joint Undertaking (IHI JU), the consortium will focus on developing the GRIPonMASH Diagnostic Platform which will allow early detection of patients with MASH, better patient stratification and personalized lifestyle advice.

'I learned to look at patients specifically'

Hans Merks, professor of paediatric soft tissue and bone sarcomas at UMC Utrecht, delivered his oration on Friday 2 February, titled 'Look and marvel'. A speech about sarcoma research, deeper layers that you only start to see when you realise it and the search for effective treatments for children.